Filed Pursuant to Rule 424(b)(2)
Registration Statement Nos. 333-290665 and 333-290665-01
(To Prospectus dated December 8, 2025, Prospectus Supplement dated December 8, 2025 and Product Supplement EQUITY MLI-1
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 1-SA
☒ SEMIANNUAL REPORT PURSUANT TO REGULATION A
or
☐ SPECIAL FINANCIAL REPORT PURSUANT TO REGULATION A
For the fiscal semiannual period ended: June 30, 2026
Next Thing Technologies Inc.
(Exact name of issuer as specified in its charter)
Delaware ... (continue reading...)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION
UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934
OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934.
ONEOK, INC.
(Exact name of registrant as specified in its charter)
Oklahoma 001-13643 73-1520922 (State... (continue reading...)
Filed pursuant to Rule 424(b)(3)
Registration No. 333-282465
Prospectus
Bitwise XRP ETF
Shares
The Bitwise XRP ETF (the “Trust”) is an exchange-traded product that issues common shares of beneficial interest (“Shares”) that are listed on NYSE Arca, Inc. (the “Exchange”) under the ticker symbol “XRP.” The Trust’s investment objective is to seek to provide exposure to the value of XRP held by the Trust, less the expenses of the Trust’s... (continue reading...)
The information in this preliminary pricing supplement is not complete and may be changed. This preliminary pricing supplement and the accompanying prospectus, prospectus supplement and underlying supplement do not constitute an offer to sell the Notes and we are not soliciting an offer to buy the Notes in any state where the offer or sale is not permitted.
Subject to Completion
Preliminary Pricing Supplement dated September 28, 2026
Pricing... (continue reading...)
More SEC Filings
View Older Stories-
Form 8-K U S PHYSICAL THERAPY For: Sep 22
-
Form 4 Finward Bancorp For: Sep 25 Filed by: Lowry Robert T
-
Form 424B2 BANK OF NOVA SCOTIA
-
Form 4 Guardian Pharmacy Servic For: Sep 27 Filed by: Tuch Jeffrey
-
Form 424B2 BofA Finance LLC
-
Form 10-D JPMBB Commercial Mortgag For: Sep 17
-
Form 485BPOS Prudential Government
-
Form 4 Guardian Pharmacy Servic For: Sep 27 Filed by: Forbes Kendall
-
Form 424B2 BofA Finance LLC
-
Form 8-K CervoMed Inc. For: Sep 28
-
Form D/A Pinebrooke Development
-
Form 40-17F2 BNY Mellon Investment Filed by: BNY Mellon Investment Funds VII, Inc.
-
Form D/A Evoke Innovation Fund
-
Form 485BPOS ETF Opportunities Trust
-
Form 8-K/A ACCENDRA HEALTH INC/VA/ For: Sep 16
-
Form FWP Citigroup Global Markets Filed by: Citigroup Global Markets Holdings Inc.
-
Form FWP CITIGROUP INC Filed by: CITIGROUP INC
-
Form 10-D JPMBB Commercial Mortgag For: Sep 17
-
Form 8-K FARADAY FUTURE INTELLIGE For: Sep 25
-
Form 4 AMBARELLA INC For: Sep 25 Filed by: PAISLEY CHRISTOPHER B
-
Form 1-SA Energy Exploration Techn For: Jun 30
-
Form 424B2 CITIGROUP INC
-
Form 485BXT Corgi ETF Trust I
-
Form 10-D JPMCC Commercial Mortgag For: Sep 17
-
Form 40-17F2 BNY Mellon Sustainable Filed by: BNY Mellon Sustainable U.S. Equity Fund, Inc.
-
Form 8-K SAN JUAN BASIN ROYALTY For: Sep 28
-
Form 4 Guardian Pharmacy Servic For: Sep 27 Filed by: BINDLEY WILLIAM E
-
Form 424B2 CITIGROUP INC
-
Form 8-K Inhibrx Biosciences, For: Sep 28
-
Form 1-SA Arrived Homes, LLC For: Jun 30
-
Form FWP BANK OF MONTREAL /CAN/ Filed by: BANK OF MONTREAL /CAN/
-
Form 424B2 CITIGROUP INC
-
Form ABS-EE JPMCC Commercial Mortgag For: Sep 17
-
Form 424B2 BARCLAYS BANK PLC
-
Form 4 Doximity, Inc. For: Sep 24 Filed by: ZATZ STEVEN L
-
Form D/A SOF Electricity Holdings
-
Form 4 ZIPRECRUITER, INC. For: Sep 25 Filed by: SAKAMOTO RYAN T.
-
Form 485BPOS Community Capital Trust
-
Form 424B2 CITIGROUP INC
-
Form 424B2 BofA Finance LLC
-
Form 40-17F2 BNY Mellon Intermediate Filed by: BNY Mellon Intermediate Municipal Bond Fund, Inc.
-
Form 424B2 BofA Finance LLC
-
Form SCHEDULE 13D/A Guardian Pharmacy Servic Filed by: Bindley Capital Partners I, LLC
-
Form D Gaingels Palabra AI LLC
-
Form 424B2 BofA Finance LLC
-
Form D/A SOF Electricity Holdings
-
Form C/A Saleen Automotive, Inc.
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 424B2 BARCLAYS BANK PLC
-
Form 4/A AtlasClear Holdings, For: Sep 24 Filed by: Patel Sandip I

